Every year I look into my stem cell crystal ball and make predictions for our field including regenerative medicine. Well, I don’t really look into a crystal ball, but I try to use a combination of what I’m hearing through the grapevine, stuff I’m reading, some info that is not yet in the public domain, …
20 predictions for stem cells & regenerative medicine in 2018 Read More »
The votes are in and the community has picked its top 10 Stem Cell Person of the Year Award finalists. Both the 20 nominees and now the 10 finalists are a diverse group. The finalists include six women and four men, from five countries and four different continents. We also got votes from readers of the blog …
10 Stem Cell Person of the Year Award Finalists 2017 Read More »
Nominations are now open for the 2017 Stem Cell Person of the Year Award, which will be our sixth such award. You can leave nominations as comments on this post or email them to me (see my email on our Contact page). The Stem Cell Person of the Year Award is an honor I give out …
Stem Cell Person of the Year 2017 Award: Nominations Open Read More »
Who are the top stem cell influencers? Terrapin asked this kind of question to some within our community 4 years ago and came up with a Top 50 list of stem cell influencers, which I like to joke I was “at the top of” because I was #50 and they listed us in reverse chronological order. …
List of Top 50 stem cell influencers on Twitter to follow Read More »
I received a score of great nominations for the Stem Cell Person of the Year 2016 Award and have briefly described the twenty nominees below. The point of the award is to honor the top positive stem cell leader who specifically thinks outside the box and takes risks. I’ve started an on-line vote where you can vote once per day for …
20 Nominees for Stem Cell Person of the Year 2016 Award Read More »
Cynata Therapeutics Limited has received approval from UK regulators to start a first-of-its-kind allogeneic IPSC-based trial of MSCs for graft versus host disease (GVHD). Cynata also had some big news a couple weeks back with a deal with Fujifilm. The company is aiming to recruit 16 patients to test whether the MSCs (a type of adult …
Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD Read More »
Nominations are open starting today for the Stem Cell Person of the Year Award for 2016. Please email me your nominations: knoepflerATucdavisDOTedu. This is a unique award as it is given to an individual who has taken risks to help others within the stem cell field and they based their actions on outside-the-box thinking. Another …
Nominations open for Stem Cell Person of the Year 2016 Award Read More »
Something very unusual and positive just happened at this year’s ISSCR meeting. Every year in December I give out an award for the Stem Cell Person of the Year to the individual with the strongest positive impact in the stem cell field generated specifically from outside-the-box thinking and actions. Dr. Jeanne Loring was the recipient in …
At ISSCR 2016, $2,000 donation to Summit For Stem Cell patient group Read More »
A committee of the International Society for Stem Cell Research (ISSCR) did one heck of a document dump yesterday on stem cell policy, releasing a whole bunch of policy recommendations on stem cells and more. The torrent from ISSCR included a 37-page policy statement itself as well as several papers in top journals including the …
What’s better for stem cell trials such as for vision loss or Parkinson’s Disease: allogeneic or autologous cells? In a major shift earlier this year, the induced pluripotent stem (IPS) cell trial in Japan for treatment of macular degeneration (MD) switched gears from using the patients’ own cells (called “autologous”) to using banked cells from …
Parkinson’s IPS cell trial in Japan switching to allogeneic Read More »